ativan

Generic: lorazepam

Labeler: hikma pharmaceuticals usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name ativan
Generic Name lorazepam
Labeler hikma pharmaceuticals usa inc.
Dosage Form INJECTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

lorazepam 2 mg/mL

Manufacturer
Hikma Pharmaceuticals USA Inc.

Identifiers & Regulatory

Product NDC 0641-6001
Product ID 0641-6001_209b0091-c890-4f69-a693-d0594c2606fe
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018140
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 1980-07-25

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 06416001
Hyphenated Format 0641-6001

Supplemental Identifiers

RxCUI
206819 206820 238100 238101 1665188 1665190 1665326 1665327
UNII
O26FZP769L
NUI
N0000175694 M0002356

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ativan (source: ndc)
Generic Name lorazepam (source: ndc)
Application Number NDA018140 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 25 VIAL in 1 CARTON (0641-6001-25) / 1 mL in 1 VIAL (0641-6001-01)
source: ndc

Packages (1)

Ingredients (1)

lorazepam (2 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "209b0091-c890-4f69-a693-d0594c2606fe", "openfda": {"nui": ["N0000175694", "M0002356"], "unii": ["O26FZP769L"], "rxcui": ["206819", "206820", "238100", "238101", "1665188", "1665190", "1665326", "1665327"], "spl_set_id": ["5fc0e987-61c9-40c4-b0d5-fcea07c8733e"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (0641-6001-25)  / 1 mL in 1 VIAL (0641-6001-01)", "package_ndc": "0641-6001-25", "marketing_start_date": "19800725"}], "brand_name": "Ativan", "product_id": "0641-6001_209b0091-c890-4f69-a693-d0594c2606fe", "dosage_form": "INJECTION", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "0641-6001", "dea_schedule": "CIV", "generic_name": "Lorazepam", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ativan", "active_ingredients": [{"name": "LORAZEPAM", "strength": "2 mg/mL"}], "application_number": "NDA018140", "marketing_category": "NDA", "marketing_start_date": "19800725", "listing_expiration_date": "20261231"}